| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Interpres is a Threat Informed Defense Surface Management Platform that fuses and operationalizes prioritized adversarial techniques, tactics, and procedures with your unique threat profile, your unique security stack and finished intelligence to identify coverage gaps, prioritize actions, optimize defenses and reduce risk. Interpres Security makes security performance intelligible and provable for the enterprise with a comprehensive new approach to managing the defense surface. With Interpres, security teams can take a threat-informed perspective to understand what their current tools can detect and defend against, identify gaps and inefficiencies, and iteratively improve their security posture with a data-driven and custom tailored approach.
CISO stands for chief information security officer, which is the key role charged with supporting the business and senior management with making informed decisions about information security for any organization. CISOSHARE sets out to fix this problem ...
Acumen Technology is an IT services provider that offers cybersecurity and security-focused IT solutions to drive business growth and protect organizations.
IQMS uniquely combines ERP and manufacturing execution system (MES) functionality to give manufacturers a comprehensive end-to-end suite for running the business, backed by the real-time performance and scalability that companies demand. Developed specifically for mid-market repetitive, discrete and batch process manufacturers, IQMS provides robust capabilities for addressing strict customer and regulatory certification and compliance.